Fighting obesity, slashing physician administrative burdens and fostering more inclusive clinical trials are the areas that the American Medical Association’s Silicon Valley subsidiary, Health2047’s three most recent spin outs are aiming to improve, the AMA reports.
In the first two quarters of 2021, Health2047 launched three companies:
Phenomix Sciences, which addresses the issues of obesity in the United States.
Emergence Healthcare Group, which offers physicians a “turnkey practice” solution that allows physicians to focus on practicing medicine. The company aims to cut administrative and financial burdens private practice physicians face.
The third company, SiteBridge Research, aims to make clinical trials more accessible to community-based physician practices through a “trial-in-a-box” platform that provides access to clinical research training, resources and support throughout the trial process. Read more.
